Galveston, TX – Prominently featured in The Inner Circle, Barbara W Sasser, PhD is acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for her contributions to Biochemistry and Genetic Research.
With more than three decades of experience in the fields of biochemistry and genetic research, Barbara W. Sasser, PhD, continues to make a profound impact on scientific advancement and patient advocacy. Since 2022, Dr. Sasser has served as the President and Chief Executive Officer of the Monoamine Oxidase Deficiency Foundation, a national charitable organization dedicated to raising awareness and funding critical research for monoamine oxidase deficiency—a rare genetic disorder that primarily affects males and is characterized by behavioral challenges and aggression due to a deficiency of the Monoamine Oxidase enzymes.
Under Dr. Sasser’s leadership, the Foundation has accelerated efforts to develop effective treatments and pursue a long-term cure for those affected by this debilitating condition. Her expertise in biochemistry, coupled with a deep commitment to the patient community, has positioned the organization as a leader in the fight against this rare genetic disease.
Dr. Sasser’s academic background includes a Bachelor of Science in Biology from Vanderbilt University (1975) and a PhD in Biochemistry from the University of Texas Medical Branch at Galveston (1983). Beyond her scientific accomplishments, she has produced a holocaust rescue documentary , “Rescue in the Philippines: Refuge from the Holocaust”, as well as being a certified teaching professional with the United States Professional Tennis Association since 2006, reflecting her multifaceted talents.
She is an active member of several professional and civic organizations, including the National Association of Professional Women, the Alliance for Regenerative Medicine, the American Society of Gene & Cell Therapy, and the United States Tennis Association. Her commitment to community service has also included leadership roles such as President of Temple B’nai Israel (2013–2015) and decades of service on the board of the Harris and Eliza Kempner Fund, including 40 years in various leadership capacities.
Looking ahead, Dr. Sasser remains unwavering in her mission to drive innovation in genetic research and support families impacted by monoamine oxidase deficiency. She plans to continue her work in the field for as long as possible, driven by a passion to discover meaningful solutions and improve lives.
About Author
